I've expressed the opinion once before, and I'll express it again....$5 is a joke imo.  

Zacks, to me its coverage that caters almost exclusively to retail mutts like me....I don't think for a second that bigger players pay their reports any mind at all.  Putting that $5 target out there though, I would wager dollars to donuts that it will convince some to sell at least some shares in and around that price assuming we get there.  

On another note I posted the other day about the cup or bowl pattern.....it occured to me that the same longer term psychology could also be playing out interday.  We get a big climb at the opening bell, we all see that $3.37 jump in OTC trading (so what if its just a 100 share trade) and start salavating like Pavlov's dog.  Then we pull back....trade sideways most of the day, and then if it goes according to the way I'm thinking it could....be climb back to that level at the close.

IMO RVX has been under accumulation for a long time, certainly since the Assure trial seemingly failed....but back in 2014/15/16/17 and earlier this year, there was ample time.  Now the time is short, BETonMACE is slated to be done inside of 6 months.  We could have a Nasdaq lisint coming.....c

Now the fun and games that I believe were designed to convince retail players to let go of their shares at bargain basement prices, oh well...if Apabetalone succeeds and takes Resverlogix to a multi billion dollar valuation...then $5 will still be incredibly cheap, better than $1 or $2 certainly...but nowhere near the value they'll be looking at in another year, two or three if Apabetalone succeeds in multiple indications as we're all hoping.

Time for me to sit back and relax for a bit now.....let's see how the day ends up.